Article Details
Retrieved on: 2024-05-29 21:48:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The US FDA has approved the first biosimilar version of AstraZeneca/Alexion's Soliris therapy for paroxysmal nocturnal haemoglobinuria (PNH) and ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here